SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | 0.0% | 81 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 81 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 81 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 81 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -85.0% | 81 | -80.5% | 0.00% | – |
| Q4 2018 | $40,000 | -25.9% | 416 | +8.9% | 0.00% | – |
| Q3 2018 | $54,000 | -61.7% | 382 | -83.1% | 0.00% | -100.0% |
| Q3 2017 | $141,000 | -91.6% | 2,263 | -93.1% | 0.00% | -87.5% |
| Q4 2016 | $1,673,000 | +10.5% | 32,764 | -0.3% | 0.01% | 0.0% |
| Q3 2016 | $1,514,000 | +53.1% | 32,865 | +0.1% | 0.01% | +60.0% |
| Q2 2016 | $989,000 | -8.8% | 32,828 | -3.0% | 0.01% | -16.7% |
| Q1 2016 | $1,085,000 | -43.3% | 33,849 | +3.1% | 0.01% | -45.5% |
| Q4 2015 | $1,914,000 | +37.7% | 32,830 | -0.0% | 0.01% | +37.5% |
| Q3 2015 | $1,390,000 | +34.8% | 32,831 | +132.4% | 0.01% | +60.0% |
| Q2 2015 | $1,031,000 | +51450.0% | 14,128 | +33538.1% | 0.01% | – |
| Q1 2015 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |